Real-time enrollment status for this relapsed or refractory multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:06 PM UTC
| NCT Number | NCT05652335 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 180 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT05652335 is currently recruiting participants. This phase1 study for relapsed or refractory multiple myeloma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05652335 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05652335 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.